biotech · Systemic Lupus Erythematosus · Primary Progressive Multiple Sclerosis (PPMS) · ZBIO
Zenas BioPharma
Zenas BioPharma trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
1000 Winter St, Suite 1200, Waltham, MA 02451, US HQ
176 Employees
Public company Type
ZBIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1000 Winter St, Suite 1200, Waltham, MA 02451, US
- Employees
- 176
- Programs
- 13
- Drugs
- 10
- Patents
- 0
Zenas BioPharma clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Zenas BioPharma programs — each row shows trial ID, program name, phase, status, and indication.
Zenas BioPharma trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Zenas BioPharma.
-
ZB012-02-002 — Phase 2
Clinical update -
ZB020-03-001 — Phase 3
Clinical update -
ZB012-02-001 — Phase 2
Clinical update -
Orelabrutinib — Phase 3
Clinical update -
Orelabrutinib — Phase 3
Clinical update -
ZB001 for injection — Phase 1
Clinical update -
ZB001 for injection — Phase 1
Clinical update -
Obexelimab — Phase 2
Clinical update